Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research
Published: January 03, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research
Published: January 03, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research
Published: January 03, 2025
Correction: p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Journal: Cancer research
Published: December 23, 2024
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series.
Journal: Therapeutic advances in medical oncology
Published: December 04, 2023
Comprehensive genomic profiling: Does timing matter?
Journal: Frontiers in oncology
Published: August 22, 2022
Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.
Journal: Journal of gastrointestinal oncology
Published: August 12, 2021
p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Journal: Cancer research
Published: October 18, 2019
Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review.
Journal: Annals of surgical oncology
Published: March 12, 2019
A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.
Journal: Annals of surgical oncology
Published: November 28, 2015
Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
Journal: Cancer biology & therapy
Published: March 18, 2015
Last Updated: 09/26/2026